Peptides are the fastest-growing import category in UAE metabolic, aesthetic, and longevity medicine, and the most common question we hear about them is also the simplest: are they legal? The answer is yes, through one defined route. This explainer sets out that route, and what happens outside it.
The direct answer
Peptides are legal to import, prescribe, and supply in the UAE through the registered pathway. A peptide product that has been classified by the Emirates Drug Establishment (EDE), registered, and imported under a valid import permit by a licensed importer is fully compliant. What the law does not allow is importation or supply outside that route.
The most important thing to understand is that the UAE does not regulate peptides as a class. The EDE decides each product's status case by case: a peptide can be classified as a biological medicinal product, as a conventional pharmaceutical, or found not eligible for registration. A result for one peptide does not transfer to the next, and a product's status in another market does not transfer to the UAE.
Classification is always step one
Until a classification decision exists, nobody can tell you a peptide's registration route, the data expectations, or the timeline. That is why every compliant peptide project starts with a classification file, not a marketing plan. We compile the file, submit it to the EDE, and obtain the decision in writing before anything else is filed.
The three decisions the EDE can make
- Biological medicinal product: registration follows the biologics route, with its own evidence expectations
- Conventional pharmaceutical: registration follows the standard EDE product registration route
- Not eligible: the product has no registration route, which is worth knowing before money is spent on a closed market
The classification decision sets everything downstream: the dossier, the evidence expectations, the timeline, and whether the product can be supplied at all.
The compliant pathway in order
Once classification is in hand, the pathway runs in a fixed sequence. Each stage depends on the one before it.
EDE classification
The classification file is compiled and submitted. The written decision sets the route for everything that follows.
Manufacturer site registration
The manufacturing site is registered with the EDE, a one-off step per site with 5-year validity.
Product registration
The registration dossier is prepared and submitted, with documents in English and Arabic, through to certificate issuance. A UAE product registration certificate is valid for 5 years.
Import permit
The EDE import permit is obtained under a licensed importer's credentials before the shipment moves.
Cold chain importation
The shipment travels under cold chain conditions and is received into a licensed GDP warehouse, with the temperature record held through storage and release.
Licensed distribution
Registered product moves from the licensed warehouse to licensed facilities only, never by direct purchase from a foreign supplier.
What happens with unregistered peptides
Under UAE law, only entities holding a pharmaceutical facility or medical warehouse licence, with the corresponding EDE import permit, may import pharmaceutical products. A peptide shipment outside that framework has no legal route into the country, and unregistered importation risks seizure and penalties.
This is worth stating plainly because much of the global peptide market runs on direct shipments from foreign suppliers. In the UAE, that supply model does not become compliant at any volume or for any buyer. If a current supply arrangement sits outside the framework, the practical fix is to move it onto the registered pathway, and we do that work.
BPC-157, GLP-1s, and the popular list
We are regularly asked for a list: which peptides are legal and which are banned. The UAE does not work from such a list. Every named compound resolves to the same question: what has the EDE decided about the specific product in front of it?
BPC-157 is a good example. Its status depends on the classification of the specific product presented to the EDE, and no product can be imported lawfully outside the registered pathway, whatever its reputation elsewhere. GLP-1 products follow the same logic: as a category they lead the metabolic segment, but each product still needs its own classification, registration, and import permits. The pattern holds across the popular list, from aesthetic to longevity peptides. Classification is the answer, per product, every time.
Where a peptide product is approved for supply, it is prescription-only: prescribed by licensed clinicians after consultation and dispensed through licensed channels. Classification decides whether a product can enter the market. It never removes the prescription layer.
Supplying peptides through telehealth
A growing share of peptide demand is fulfilled through telehealth: an online consultation with a DHA-licensed clinician, a prescription, and delivery through licensed channels. That model is available in the UAE through the licensed structure, with the registered supply chain behind it. We run both halves: the product pathway, from EDE classification to cold chain importation, through our peptide import and registration service, and the licensed operation itself through our turnkey telemedicine build.
See the peptide import and registration pathway
Frequently asked questions
Are peptides banned in the UAE?
Is BPC-157 legal in the UAE?
How are peptides classified in the UAE?
How long does peptide registration take?
What happens if peptides are imported without registration?
This explainer is general information for operators and investors, not regulatory, legal, or medical advice. Prescription medicines are prescribed by licensed clinicians after consultation. Confirm current requirements with the relevant authority or your regulatory partner before acting.